Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wyeth compliance program

Executive Summary

Bruce Burlington, MD, will oversee the company's global QA/QC for all commercial products as senior VP-regulatory affairs & compliance, a newly created position. Burlington, who was director of FDA's Center for Devices & Radiological Health before joining Wyeth as VP-regulatory affairs in 1999, will now report to Wyeth Pharmaceuticals President Bernard Poussot, in addition to Wyeth Research President Patrick Gage, MD. Senior VP-QA/QC Roy Sturgeon, PhD, will report to Burlington. Sturgeon was directly under Poussot before the organizational change. Wyeth is currently in discussions with FDA to resume production at its Marietta, Penn. facility, after a seizure action by FDA against products manufactured there. Filling of Wyeth's flu vaccine Flushield has also been halted at the plant since December (1"The Pink Sheet" June 19, p. 29)
Advertisement

Related Content

Wyeth DT Vaccine Seized By FDA; Manufacturing Upgrades Under Way
Wyeth DT Vaccine Seized By FDA; Manufacturing Upgrades Under Way
Advertisement
UsernamePublicRestriction

Register

PS036327

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel